entertainment -WSS

entertainment

author：leisure time 2025-09-30 12:10:25 - browse：361

LONDON — AstraZeneca said on Monday that a new lung cancer treatment outperformed standard-of-care chemotherapy in a trial, but investors found the results less impressive than anticipated, sending company shares down in early trading.

Based on an interim analysis of a Phase 3 trial, the company said that the drug, datopotamab deruxtecan, led to improvement in progression-free survival in patients non-small cell lung cancer, a primary endpoint of the study. There was also a positive early trend on overall survival, with Susan Galbraith, AstraZeneca’s oncology leader, describing the results as “compelling evidence for the potential role” that the drug could play for patients.

But investors had been hoping for a clearer signal of benefit. Analysts noted that despite the success in progression-free survival, it was not described as a “clinically meaningful” improvement, which, as J.P. Morgan analysts wrote, “we believe the market would have liked to have seen.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Coercive sterilizations revealed by STAT prompt outrage

WSS

California wildfire smoke linked to 52,000 early deaths, study says

Teladoc has a new CEO, but challenges remain the same

Interest rates are at a 22

New report analyzes digital physical therapy solutions' effectiveness

Moderna says combo Covid

New report analyzes digital physical therapy solutions' effectiveness

knowledge

entertainment

focus

What does generative AI mean for health care? We asked experts

Interest rates are at a 22

After affirmative action ruling, medical educators look to 'holistic review'

Bryan Kohberger seeks indictment dismissal in Idaho college killings case

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

'Essentially witchcraft:' A former naturopath takes on the field

Hepatitis C has a cure — but many Americans still lack access to it

Interest rates are at a 22

Medicare details structure of new drug price negotiation program

VC firm RA Capital starts a new synthetic biology incubator

knowledge

Stephen Quake on the Chan Zuckerberg quest to conquer disease

'Essentially witchcraft:' A former naturopath takes on the field

McConnell had minor fall 2 weeks ago, uses wheelchair periodically to get around: Sources

The Jan. 6 committee previously recommended Trump be criminally charged. Here's why

5 takeaways from STAT's examination of Zynex Medical

Moderna says combo Covid

focus

Wikipedia

hotspot

explore